Reports Q3 revenue $1.35B, consensus $1.33B. “We are very pleased with our Q3 performance as strong discharge growth facilitated an increase of 11.9% in revenue and 13.4% in Adjusted EBITDA,” said President and CEO, Mark Tarr. “Our teams did an exemplary job managing through very challenging conditions posed by Hurricanes Helene and Milton, prioritizing patient safety and continuity of operations. We thank our employees for their resilience and dedication to providing the highest quality care for our patients.”
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC: